結構性心臟封閉栓:開發中產品的分析 - 開發階段，市場區隔，地區/國家，法規途徑，主要企業等 (2022年)

本報告提供全球結構的心臟封閉栓市場上的主要開發中產品及其臨床實驗進展調查，產品特性的比較分析 (臨床實驗的各進展階段) ，再加上主要企業簡介及代表性產品，近來的市場動靜 (資本交易、事業聯盟等) 等彙整資訊，為您概述為以下內容。

目錄

第1章 目錄

第2章 簡介

• 結構的心臟封閉栓概要

第3章 現在臨床實驗中的產品

• 開發中產品:各臨床實驗階段
• 開發中產品:各市場區隔
• 開發中產品:各領域
• 開發中產品:各法規途徑
• 開發中產品:各估計核准時期
• 現在進行中的臨床實驗

第4章 在結構的心臟封閉栓:各企業現在臨床實驗中的開發中產品

• 結構的心臟封閉栓的企業:各臨床實驗階段的開發中產品
• 結構的心臟封閉栓:各臨床實驗階段的開發中產品

第5章 結構的心臟封閉栓:企業、產品概要

• Aegis Medical Innovations Inc.:企業概要
• Aporo Biomedical, Inc. (Inactive):企業概要
• Append Medical:企業概要
• atHeart Medical:企業概要
• AuriGen Medical Ltd:企業概要
• Boston Scientific Corp:企業概要
• CARAG AG:企業概要
• Cierra, Inc. (Inactive):企業概要
• Conformal Medical Inc:企業概要
• Cor Habere Corp:企業概要
• Dextera Surgical Inc:企業概要
• Ension, Inc.:企業概要
• Guangdong Pulse Medical Technology Co Ltd:企業概要
• Hangzhou Dinova EP Technology Co Ltd:企業概要
• Hansen Medical Inc (Inactive):企業概要
• Laminar Inc:企業概要
• Lepu Scientech Medical Technology (Shanghai) Co Ltd:企業概要
• Lifetech Scientific (深圳) Co Ltd:企業概要
• LuSeed Vascular:企業概要
• Mayo Clinic:企業概要
• Medtronic Plc:企業概要
• Meril Life Sciences Pvt Ltd:企業概要
• Micro Interventional Devices, Inc.:企業概要
• MicroPort Scientific Corp:企業概要
• Northwestern University:企業概要
• Occlutech International AB:企業概要
• SentreHEART Inc:企業概要
• SeptRx, Inc. (Inactive):企業概要
• Shanghai Shenqi Medical Technology Co Ltd:企業概要
• Swissimplant AG:企業概要
• The Chaim Sheba Medical Center:企業概要
• University of Minnesota:企業概要
• Vascular Closure Systems Inc:企業概要
• Vascular Concepts Ltd:企業概要
• W. L. Gore & Associates Inc:企業概要

第6章 附錄

GlobalData's Medical Devices sector report, "Structural Heart Occluders Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Structural Heart Occluders pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Structural heart occluders are used for treatment congenital heart defects by closing openings in the heart. Structural heart occluders covers left atrial appendage closure devices, atrial septal defect occluders, ventricular septal defect occluders, patent foramen ovale closure devices, patent ductus arteriosus closure devices.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Structural Heart Occluders under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Structural Heart Occluders and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Structural Heart Occluders under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Structural Heart Occluders Overview

3 Products under Development

• 3.1 Structural Heart Occluders - Pipeline Products by Stage of Development
• 3.2 Structural Heart Occluders - Pipeline Products by Segment
• 3.3 Structural Heart Occluders - Pipeline Products by Territory
• 3.4 Structural Heart Occluders - Pipeline Products by Regulatory Path
• 3.5 Structural Heart Occluders - Pipeline Products by Estimated Approval Date
• 3.6 Structural Heart Occluders - Ongoing Clinical Trials

4 Structural Heart Occluders - Pipeline Products under Development by Companies

• 4.1 Structural Heart Occluders Companies - Pipeline Products by Stage of Development
• 4.2 Structural Heart Occluders - Pipeline Products by Stage of Development

5 Structural Heart Occluders Companies and Product Overview

• 5.1 Aegis Medical Innovations Inc. Company Overview
• 5.2 Aporo Biomedical, Inc. (Inactive) Company Overview
• 5.3 Append Medical Company Overview
• 5.4 atHeart Medical Company Overview
• 5.5 AuriGen Medical Ltd Company Overview
• 5.6 Boston Scientific Corp Company Overview
• 5.7 CARAG AG Company Overview
• 5.8 Cierra, Inc. (Inactive) Company Overview
• 5.9 Conformal Medical Inc Company Overview
• 5.10 Cor Habere Corp Company Overview
• 5.11 Dextera Surgical Inc Company Overview
• 5.12 Ension, Inc. Company Overview
• 5.13 Guangdong Pulse Medical Technology Co Ltd Company Overview
• 5.14 Hangzhou Dinova EP Technology Co Ltd Company Overview
• 5.15 Hansen Medical Inc (Inactive) Company Overview
• 5.16 Laminar Inc Company Overview
• 5.17 Lepu Scientech Medical Technology (Shanghai) Co Ltd Company Overview
• 5.18 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
• 5.19 LuSeed Vascular Company Overview
• 5.20 Mayo Clinic Company Overview
• 5.21 Medtronic Plc Company Overview
• 5.22 Meril Life Sciences Pvt Ltd Company Overview
• 5.23 Micro Interventional Devices, Inc. Company Overview
• 5.24 MicroPort Scientific Corp Company Overview
• 5.25 Northwestern University Company Overview
• 5.26 Occlutech International AB Company Overview
• 5.27 SentreHEART Inc Company Overview
• 5.28 SeptRx, Inc. (Inactive) Company Overview
• 5.29 Shanghai Shenqi Medical Technology Co Ltd Company Overview
• 5.30 Swissimplant AG Company Overview
• 5.31 The Chaim Sheba Medical Center Company Overview
• 5.32 University of Minnesota Company Overview
• 5.33 Vascular Closure Systems Inc Company Overview
• 5.34 Vascular Concepts Ltd Company Overview
• 5.35 W. L. Gore & Associates Inc Company Overview

6 Appendix

• 6.1 Methodology
• 6.2 About GlobalData
• 6.3 Contact Us
• 6.4 Disclaimer

List of Tables

List of Tables

• Structural Heart Occluders - Pipeline Products by Stage of Development
• Structural Heart Occluders - Pipeline Products by Segment
• Structural Heart Occluders - Pipeline Products by Territory
• Structural Heart Occluders - Pipeline Products by Regulatory Path
• Structural Heart Occluders - Pipeline Products by Estimated Approval Date
• Structural Heart Occluders - Ongoing Clinical Trials
• Structural Heart Occluders Companies - Pipeline Products by Stage of Development
• Structural Heart Occluders - Pipeline Products by Stage of Development
• Glossary

List of Figures

List of Figures

• Structural Heart Occluders - Pipeline Products by Stage of Development
• Structural Heart Occluders - Pipeline Products by Segment
• Structural Heart Occluders - Pipeline Products by Territory
• Structural Heart Occluders - Pipeline Products by Regulatory Path
• Structural Heart Occluders - Pipeline Products by Estimated Approval Date
• Structural Heart Occluders - Ongoing Clinical Trials